S&P Dow Jones Indices announced after Wednesday's market close that WebMD Health Corp. WBMD will replace Sunedison Inc SUNE within the S&P MidCap 400 index.
According to the index operator, Sunedison's market cap is ranked at the bottom of the index and has a market capitalization that "is no longer representative of the mid-cap market space."
Related Link: Sunedison Plunges Under $1 Following Report Of SEC Probe, TerraForm Global 8K
Shares of Sunedison have lost nearly 90 percent of its value since the start of 2016 and is trading with a market capitalization of around $80 million versus WebMD's $2.33 billion valuation.
Shares of WebMD were trading higher by nearly 3 percent following the announcement.
S&P Dow Jones Indices also announced that SciClone Pharmaceuticals, Inc. SCLN will replace Affymetrix, Inc. AFFX in the S&P SmallCap 600 index as Affymetrix is set to be acquired by Thermo Fisher Scientific Inc. TMO.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.